Literature DB >> 10760476

Long chain fatty acids inhibit and medium chain fatty acids activate mammalian cardiac hexokinase.

J M Stewart1, J A Blakely.   

Abstract

We investigated the effect of non-esterified fatty acids (FAs) on bovine heart hexokinase (type I: ATP: D-hexose 6-phosphotransferase, EC 2.7.1.1). Long chain FAs (C14 to C20) inhibited the enzyme in a way that correlated positively with both the chain length and the degree of unsaturation. Medium chain FA with 12 or less carbons activated hexokinase in a chain length dependent manner with the greater activation shown by laurate. The activation constant of laurate was 91.5 microM with a maximal activation of 60.3%. Oleate caused a maximal decrease in specific activity of 25% with an inhibition constant of 79 microM. Using the fluorescent probe cis-parinarate, we found a saturable binding site with K(d) of 3.5 microM. Oleate competed the fluorescent probe from the protein with a K(d) of 1.4 microM. Medium chain FAs did not compete the probe from HK. The binding of fatty acid to the protein appears to be entropically driven as indicated by an Arrhenius analysis (DeltaS=+231.6 J mol(-1) deg(-1)). The presence of oleate significantly increased the K(ATP)(m) from 0.47 mM to 0.89 mM while the K(glucose)(m) in the presence of the FA (0.026+/-0.003 mM) was not significantly different from the control (0.014+/-0.004 mM). A decrease in V(max) values in the presence of oleate indicated that a mixed allosteric inhibition was operating.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760476     DOI: 10.1016/s1388-1981(00)00008-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.

Authors:  Meredith T Morris; Courtney DeBruin; Zhaoqing Yang; Jeremy W Chambers; Kerry S Smith; James C Morris
Journal:  Eukaryot Cell       Date:  2006-10-06

Review 2.  Lipids, mitochondria and cell death: implications in neuro-oncology.

Authors:  Alison Colquhoun
Journal:  Mol Neurobiol       Date:  2010-04-29       Impact factor: 5.590

Review 3.  Protein-lipid complexes: molecular structure, current scenarios and mechanisms of cytotoxicity.

Authors:  Esmail M El-Fakharany; Elrashdy M Redwan
Journal:  RSC Adv       Date:  2019-11-13       Impact factor: 4.036

4.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

Review 5.  FABPs as determinants of myocellular and hepatic fuel metabolism.

Authors:  B Binas; E Erol
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

6.  Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.

Authors:  Serena Giuliano; Anna Maria Agresta; Antonella De Palma; Simona Viglio; Pierluigi Mauri; Marco Fumagalli; Paolo Iadarola; Lorenza Montalbetti; Roberta Salvini; Anna Bardoni
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

7.  Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.

Authors:  J Allen Crow; Katye L Herring; Shuqi Xie; Abdolsamad Borazjani; Philip M Potter; Matthew K Ross
Journal:  Biochim Biophys Acta       Date:  2009-09-15

8.  Combined administration of lauric acid and glucose improved cancer-derived cardiac atrophy in a mouse cachexia model.

Authors:  Shota Nukaga; Takuya Mori; Yoshihiro Miyagawa; Rina Fujiwara-Tani; Takamitsu Sasaki; Kiyomu Fujii; Shiori Mori; Kei Goto; Shingo Kishi; Chie Nakashima; Hitoshi Ohmori; Isao Kawahara; Yi Luo; Hiroki Kuniyasu
Journal:  Cancer Sci       Date:  2020-10-02       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.